Progyny (Progyny) Forward Dividend Yield % : 0.00% (As of Apr. 30, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Progyny Forward Dividend Yield %?

As of today (2024-04-30), the Forward Annual Dividend Yield of Progyny is 0.00%.

As of today (2024-04-30), the Trailing Annual Dividend Yield of Progyny is 0.00%.

PGNY's Forward Dividend Yield % is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 2.28
* Ranked among companies with meaningful Forward Dividend Yield % only.

Progyny's Dividends per Share for the three months ended in Dec. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Progyny's Forward Dividend Yield %

For the Health Information Services subindustry, Progyny's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Progyny's Forward Dividend Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Progyny's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Progyny's Forward Dividend Yield % falls into.

Progyny Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Progyny (NAS:PGNY) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Progyny Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Progyny's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Progyny (Progyny) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Progyny Inc (NAS:PGNY) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1359 Broadway, New York, NY, USA, 10018

Website

https://www.progyny.com

Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.

Executives

David J Schlanger	director, officer: Executive Chairman	C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK NY 10018
Michael E Sturmer	officer: President	48 LEDYARD RD, WEST HARTFORD CT 06117
Mark S. Livingston	officer: Chief Financial Officer	C/O PROGYNY, INC., 1359 BROADWAY, 2ND FL, NEW YORK NY 10018
Kevin K Gordon	director	155 S LIMERICK RD, LIMERICK PA 19468
Tpg Gp A, Llc	10 percent owner	301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Peter Anevski	officer: Chief Executive Officer	C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK NY 10018
Cheryl Scott	director	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Norman Payson	director	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Allison Swartz	officer: EVP, GC	C/O PROGYNY, INC., 1359 BROADWAY, NEW YORK NY 10018
Lloyd H Dean	director	185 BERRY STREET, SUITE 300, SAN FRANCISCO CA 94107
Monice Barbero	officer: EVP, GC and Secretary	C/O PROGYNY, INC., 1359 BROADWAY, NEW YORK NY 10018
Jon Winkelried	10 percent owner	C/O GOLDMAN, SACHS & CO., 85 BROAD STREET, NEW YORK NY 10004
Beth C Seidenberg	director
Jennifer Bealer	officer: EVP, General Counsel	C/O PROGYNY, INC., 245 5TH AVENUE, NEW YORK NY 10016
Malissia Clinton	director	333 THREE D SYSTEMS CIRCLE, ROCK HILL SC 29730